Managed Care Calendar
- AAPM 2010 Clinical Meeting
Poll
Issue
- Issue:June 2009
Cites Insufficient Evidence of Improved Outcomes Genetic testing can provide physicians with information to help them estimate the best starting dose and titration regimen for treatment with the blood thinner warfarin, but in early May the Centers for Medicare & Medicaid Services (CMS) announced a decision to decline payment for warfarin genetic testing unless administered as part of a clinical trial comparing outcomes in tested and untested patients. Although CMS’ decision has been characterized as a setback for personalized medicine, the abundance of variables other than genotype th
- Issue:June 2009
Government-run Insurance Seen as Step Toward Nationalization
Stakeholders are united in their support for healthcare reform, but the proposal to create a public, government-run health plan has become a major point of disagreement, with private insurers asserting that they could not compete with such a plan. Critics of the public option say it will move the country toward a single-payer system by eroding private enrollment and exacerbating cost shifting, but defenders say competition will be beneficial and that individuals and businesses could still choose private insurance if they prefer. S
- Issue:June 2009
REQUIP XL is an oral dopamine agonist medication for Parkinson’s disease and had demonstrated significant improvement in the symptoms of Parkinson’s disease.
The Role of Immune Function in the Changing Landscape of RRMS Therapies
Gastroesophageal reflux disease (GERD) is an important
managed care health concern because it is one of the most common gastrointestinal (GI) disorders in the United
States. GERD affects nearly 18.6 million Americans, according to a national healthcare database analysis.
Parkinson’s disease (PD) is a progressive
and disabling neurologic disorder. The disease is the most prevalent type of parkinsonism, a clinical syndrome caused by lesions in the basal ganglia, predominantly in the substantia nigra, which produces deficits in motor behavior.Continuing Education
HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2010 HMP Communications
© 2010 HMP Communications, LLC
